EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Current development of molecular classifications of gastric cancer based on omics (Review)

Yubo Ma, Zhengchen Jiang, Libin Pan, Ying Zhou, Ruihong Xia, Zhuo Liu, Li Yuan

International Journal of Oncology · 01.08.2024 · 65 (3)

DOI: 10.3892/ijo.2024.5677 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 01.08.2024. Verfasst von Yubo Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Proteomics, Biomarkers, Tumor, Metabolomics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a complex and heterogeneous disease with significant phenotypic and genetic variation. Traditional classification systems rely mainly on the evaluation of clinical pathological features and conventional biomarkers and might not capture the diverse clinical processes of individual GCs. The latest discoveries in omics technologies such as next‑generation sequencing, proteomics and metabolomics have provided crucial insights into potential genetic alterations and biological events in GC. Clustering strategies for identifying subtypes of GC might offer new tools for improving GC treatment and clinical trial outcomes by enabling the development of therapies tailored to specific subtypes. However, the feasibility and therapeutic significance of implementing molecular classifications of GC in clinical practice need to addressed. The present review examines the current molecular classifications, delineates the prevailing landscape of clinically relevant molecular features, analyzes their correlations with traditional GC classifications, and discusses potential clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsProteomicsBiomarkers, TumorMetabolomicsHumansHigh-Throughput Nucleotide SequencingGenomics

Stichwörter der Autor:innen

cluster classificationgastric cancerheterogeneitytherapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
  • Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, P.R. China.
  • Department of Pharmacy, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310005, P.R. China.
  • Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.

Zitieren

APA

Ma, Y., Jiang, Z., Pan, L., Zhou, Y., Xia, R., Liu, Z., & Yuan, L. (2024). Current development of molecular classifications of gastric cancer based on omics (Review). International Journal of Oncology, 65(3). https://doi.org/10.3892/ijo.2024.5677

Vancouver

Ma Y, Jiang Z, Pan L, Zhou Y, Xia R, Liu Z, et al. Current development of molecular classifications of gastric cancer based on omics (Review). International Journal of Oncology. 2024;65(3). doi:10.3892/ijo.2024.5677

BibTeX
@article{Ma2024,
  author = {Ma, Yubo and Jiang, Zhengchen and Pan, Libin and Zhou, Ying and Xia, Ruihong and Liu, Zhuo and Yuan, Li},
  title = {Current development of molecular classifications of gastric cancer based on omics (Review)},
  journal = {International Journal of Oncology},
  year = {2024},
  volume = {65},
  number = {3},
  doi = {10.3892/ijo.2024.5677}
}
Kostenlos starten →